ClinicalTrials.govpublic full text
A Study of Pembrolizumab With Trastuzumab and Chemotherapy in People With Esophagogastric Cancer
esophageal cancer, gastric adenocarcinoma, her2 gene mutation, her2+ esophageal cancer, her2+ gej cancer, her2 ihc3+ expression, ihc 2+/fish>2.0 expression, esophagogastric cancer, memorial sloan kettering cancer center, 23-124, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 852006
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.